163 results about "Multiple dose" patented technology

The present invention is directed to pharmaceutical compositions that allow for once-daily or alternate day dosage forms of topiramate. The proposed delayed/extended release single dosage form is equivalent to the immediate-release multiple dose daily regimen, and upon administration, provides steady state blood levels of topiramate. Formulations with increased bioavailability and improved pharmacokinetics are disclosed. A once-a-day administration of topiramate is advantageous over the multiple dose regimen both in terms of patient compliance and reduced adverse events, thus providing better treatment of the conditions for which the topiramate is indicated.

Methods of forming conformal films that reduce the amount of metal-containing precursor and/or silicon containing precursor materials required are described. The methods increase the amount of film grown following each dose of metal-containing and/or silicon-containing precursors. The methods may involve introducing multiple doses of the silicon-containing precursor for each dose of the metal-containing precursor and/or re-pressurizing the process chamber during exposure to a dose of the silicon-containing precursor. The methods of the present invention are particularly suitable for use in RVD processes.

The present invention provides an inventive apparatus and method for docking of a male luer connector fluidly interconnected or interconnectable to a medical liquid source during one or repeated periods. As such, the invention has particular application to multiple-dose medication therapy procedures. The docking apparatus comprises a holding receptacle having a single access opening and a depressible member disposed in the holding receptacle. The holding receptacle is adapted for retentive engagement with a male luer connector (e.g. via complementary threading), wherein upon docking a nozzle of the male luer connector is isolated within the holding receptacle. An anti-bacterial material may be readily applied to a top surface of the depressible member prior to docking so that the forward edge of the nozzle of the male luer connector contacts the anti-bacterial material when docked. The docking apparatus may be provided with lateral and rearward handling members to facilitate docking procedures. Additionally, slots may be provided for interconnecting the docking apparatus to a tubing line at a patient site.